288 related articles for article (PubMed ID: 18805667)
21. The potential of glycol chitosan nanoparticles as carrier for low water soluble drugs.
Trapani A; Sitterberg J; Bakowsky U; Kissel T
Int J Pharm; 2009 Jun; 375(1-2):97-106. PubMed ID: 19481695
[TBL] [Abstract][Full Text] [Related]
22. Preparation of chitosan beads by simultaneous cross-linking/insolubilisation in basic pH. Rheological optimisation and drug loading/release behaviour.
Barreiro-Iglesias R; Coronilla R; Concheiro A; Alvarez-Lorenzo C
Eur J Pharm Sci; 2005 Jan; 24(1):77-84. PubMed ID: 15626580
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of sodium hexameta phosphate cross-linked chitosan microspheres for controlled and sustained delivery of centchroman.
Gupta KC; Jabrail FH
Int J Biol Macromol; 2006 May; 38(3-5):272-83. PubMed ID: 16620951
[TBL] [Abstract][Full Text] [Related]
24. Influence of chitosan crosslinking on bitterness of mefloquine hydrochloride microparticles using central composite design.
Shah PP; Mashru RC
J Pharm Sci; 2009 Feb; 98(2):690-703. PubMed ID: 18563807
[TBL] [Abstract][Full Text] [Related]
25. [Preparation of uniform-sized chitosan microspheres and application as carriers for protein drugs].
Gu YH; Wang LY; Tan TW; Ma GH
Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):150-5. PubMed ID: 16572856
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
[TBL] [Abstract][Full Text] [Related]
27. Chitosan-DNA microparticles as mucosal delivery system: synthesis, characterization and release in vitro.
Li YH; Fan MW; Bian Z; Chen Z; Zhang Q; Yang HR
Chin Med J (Engl); 2005 Jun; 118(11):936-41. PubMed ID: 15978195
[TBL] [Abstract][Full Text] [Related]
28. Covalent and ionic co-cross-linking--an original way to prepare chitosan-gelatin hydrogels for biomedical applications.
Jătariu Cadinoiu AN; Popa M; Curteanu S; Peptu CA
J Biomed Mater Res A; 2011 Sep; 98(3):342-50. PubMed ID: 21626665
[TBL] [Abstract][Full Text] [Related]
29. Design and development of gliclazide-loaded chitosan microparticles for oral sustained drug delivery: in-vitro/in-vivo evaluation.
Barakat NS; Almurshedi AS
J Pharm Pharmacol; 2011 Feb; 63(2):169-78. PubMed ID: 21235580
[TBL] [Abstract][Full Text] [Related]
30. Encapsulation of adenoviral vectors into chitosan-bile salt microparticles for mucosal vaccination.
Lameiro MH; Malpique R; Silva AC; Alves PM; Melo E
J Biotechnol; 2006 Nov; 126(2):152-62. PubMed ID: 16757053
[TBL] [Abstract][Full Text] [Related]
31. A novel method for the synthesis of the PEG-crosslinked chitosan with a pH-independent swelling behavior.
Kulkarni AR; Hukkeri VI; Sung HW; Liang HF
Macromol Biosci; 2005 Oct; 5(10):925-8. PubMed ID: 16208628
[TBL] [Abstract][Full Text] [Related]
32. Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies.
García A; Leonardi D; Piccirilli GN; Mamprin ME; Olivieri AC; Lamas MC
Drug Dev Ind Pharm; 2015 Feb; 41(2):244-52. PubMed ID: 24237328
[TBL] [Abstract][Full Text] [Related]
33. A biodegradable and biocompatible drug-delivery system based on polyoxalate microparticles.
Lee E; Kim S; Seong K; Park H; Seo H; Khang G; Lee D
J Biomater Sci Polym Ed; 2011; 22(13):1683-94. PubMed ID: 20699060
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of a model protein into chitosan-bile salt microparticles.
Lameiro MH; Lopes A; Martins LO; Alves PM; Melo E
Int J Pharm; 2006 Apr; 312(1-2):119-30. PubMed ID: 16480840
[TBL] [Abstract][Full Text] [Related]
35. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
36. Stability improvement of electrospun chitosan nanofibrous membranes in neutral or weak basic aqueous solutions.
Sangsanoh P; Supaphol P
Biomacromolecules; 2006 Oct; 7(10):2710-4. PubMed ID: 17025342
[TBL] [Abstract][Full Text] [Related]
37. Morphology and characterization of 3D micro-porous structured chitosan scaffolds for tissue engineering.
Hsieh WC; Chang CP; Lin SM
Colloids Surf B Biointerfaces; 2007 Jun; 57(2):250-5. PubMed ID: 17363229
[TBL] [Abstract][Full Text] [Related]
38. Preparation of ionic-crosslinked chitosan-based gel beads and effect of reaction conditions on drug release behaviors.
Chen S; Liu M; Jin S; Wang B
Int J Pharm; 2008 Feb; 349(1-2):180-7. PubMed ID: 17900834
[TBL] [Abstract][Full Text] [Related]
39. Development of cyclodextrin microspheres for pulmonary drug delivery.
Skiba M; Bounoure F; Barbot C; Arnaud P; Skiba M
J Pharm Pharm Sci; 2005 Aug; 8(3):409-18. PubMed ID: 16401391
[TBL] [Abstract][Full Text] [Related]
40. A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect.
Hua S; Yang H; Wang A
Drug Dev Ind Pharm; 2010 Sep; 36(9):1106-14. PubMed ID: 20334540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
